Bosentan Use in Patients With Diabetic Nephropathy

PHASE3TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

June 30, 2010

Conditions
Type 2 Diabetes
Interventions
DRUG

bosentan

62.5mg bid x4 weeks, up-titrate to 125mg bid x12 weeks

Trial Locations (1)

H2L 4M1

CHUM, Montreal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Actelion

INDUSTRY

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER